1. Home
  2. SGRP vs PMN Comparison

SGRP vs PMN Comparison

Compare SGRP & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SPAR Group Inc.

SGRP

SPAR Group Inc.

HOLD

Current Price

$0.89

Market Cap

27.3M

ML Signal

HOLD

Logo ProMIS Neurosciences Inc. (ON)

PMN

ProMIS Neurosciences Inc. (ON)

HOLD

Current Price

$7.36

Market Cap

23.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SGRP
PMN
Founded
1967
2004
Country
United States
Canada
Employees
N/A
N/A
Industry
Business Services
Pharmaceuticals and Biotechnology
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.3M
23.5M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
SGRP
PMN
Price
$0.89
$7.36
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$72.67
AVG Volume (30 Days)
61.0K
39.2K
Earning Date
11-14-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$147,130,000.00
N/A
Revenue This Year
$7.22
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
21.79
N/A
52 Week Low
$0.85
$6.27
52 Week High
$2.28
$39.75

Technical Indicators

Market Signals
Indicator
SGRP
PMN
Relative Strength Index (RSI) 35.44 95.95
Support Level $0.87 $0.29
Resistance Level $0.92 $7.95
Average True Range (ATR) 0.06 0.32
MACD -0.01 0.85
Stochastic Oscillator 16.35 92.24

Price Performance

Historical Comparison
SGRP
PMN

About SGRP SPAR Group Inc.

SPAR Group Inc is a merchandising and brand marketing services company, providing a broad range of sales-enhancing services to retailers across classes of trade and consumer goods manufacturers and distributors. It also provides a range of services to retailers, consumer goods manufacturers and distributors around the globe. The company divides its operations into three reportable regional segments: Americas, which is comprised of United States, Canada, Brazil and Mexico; Asia-Pacific (APAC), which is comprised of Japan, China, and India; and Europe, Middle East and Africa (EMEA), which is comprised of South Africa. It generates maximum revenue from the Americas.

About PMN ProMIS Neurosciences Inc. (ON)

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.

Share on Social Networks: